JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
701
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.9B
| $130M | 0.02% |
283,398
+151,772
| +115% | +$70.7M |
2013 Q2
39 quarters
|
|
702
Celanese
CE
$4.85B
| $129M | 0.02% |
1,188,902
-8,420
| -0.7% | -$972K |
2013 Q2
39 quarters
|
|
703
Qorvo
QRVO
$10.1B
| $129M | 0.02% |
1,271,221
+746,216
| +142% | +$75.7M |
2015 Q1
32 quarters
|
|
704
JPMorgan BetaBuilders USD High Yield Corporate Bond ETF
BBHY
$606M
| $129M | 0.02% |
2,870,194
-1,302,176
| -31% | -$58.1M |
2016 Q4
25 quarters
|
|
705
ICU Medical
ICUI
$3.99B
| $129M | 0.02% |
779,705
+25,284
| +3% | +$4.35M |
2013 Q2
39 quarters
|
|
706
British American Tobacco
BTI
$113B
| $129M | 0.02% |
3,661,558
+64,984
| +2% | +$2.45M |
2013 Q2
39 quarters
|
|
707
KeyCorp
KEY
$21.4B
| $129M | 0.02% |
10,264,113
+4,967,503
| +94% | +$83.9M |
2013 Q2
39 quarters
|
|
708
Conagra Brands
CAG
$6.38B
| $128M | 0.02% |
3,416,559
+933,083
| +38% | +$34.6M |
2013 Q2
39 quarters
|
|
709
Occidental Petroleum
OXY
$58.1B
| $127M | 0.02% |
2,039,219
+1,217,285
| +148% | +$75.6M |
2013 Q2
39 quarters
|
|
710
CALL
Akamai
AKAM
$15.7B
| $127M | 0.02% |
1,623,400
+942,800
| +139% | +$76.3M |
2021 Q2
7 quarters
|
|
711
Emerson Electric
EMR
$90.1B
| $127M | 0.02% |
1,452,957
+1,974
| +0.1% | +$173K |
2013 Q2
39 quarters
|
|
712
Vanguard Consumer Discretionary ETF
VCR
$5.69B
| $127M | 0.02% |
501,317
+230,445
| +85% | +$56.1M |
2014 Q4
33 quarters
|
|
713
Alcoa
AA
$11.1B
| $127M | 0.02% |
2,974,192
-237,224
| -7% | -$11.4M |
2013 Q2
39 quarters
|
|
714
MACOM Technology Solutions
MTSI
$24.6B
| $125M | 0.02% |
1,770,789
+289,150
| +20% | +$19.5M |
2014 Q1
36 quarters
|
|
|
715
PUT
UnitedHealth
UNH
$334B
| $125M | 0.02% |
264,900
+160,900
| +155% | +$77.6M |
2014 Q3
34 quarters
|
|
716
Vanguard Morningstar Value ETF
VTV
$186B
| $125M | 0.02% |
901,635
-49,591
| -5% | -$6.96M |
2013 Q2
39 quarters
|
|
717
NorthWestern Energy
NWE
$4.26B
| $124M | 0.02% |
2,150,607
+233,827
| +12% | +$13.4M |
2013 Q2
39 quarters
|
|
718
iShares MSCI KLD 400 Social ETF
DSI
$5.55B
| $124M | 0.02% |
1,592,198
-122,493
| -7% | -$9.25M |
2013 Q2
39 quarters
|
|
719
General Motors
GM
$68.7B
| $124M | 0.02% |
3,375,211
-1,294,192
| -28% | -$48.9M |
2013 Q2
39 quarters
|
|
720
Datadog
DDOG
$99.5B
| $124M | 0.02% |
1,701,112
+629,466
| +59% | +$46.2M |
2019 Q3
14 quarters
|
|
721
Quaker Houghton
KWR
$2.77B
| $123M | 0.02% |
622,326
-5,300
| -0.8% | -$1.01M |
2013 Q2
39 quarters
|
|
|
SRCL
722
DELISTED
Stericycle Inc
SRCL
| $122M | 0.01% |
2,808,202
+833,215
| +42% | +$41.2M |
2013 Q2
39 quarters
|
|
723
Consolidated Edison
ED
$38.2B
| $122M | 0.01% |
1,279,492
-587,826
| -31% | -$55M |
2013 Q2
39 quarters
|
|
724
Dick's Sporting Goods
DKS
$13.4B
| $122M | 0.01% |
860,885
-152,465
| -15% | -$20.3M |
2013 Q2
39 quarters
|
|
725
Sun Life Financial
SLF
$43.7B
| $122M | 0.01% |
2,614,012
-127,687
| -5% | -$6.15M |
2013 Q2
39 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.